$CRLBF Income Statement | Understand Stock

$CRLBF

$0.78 +$0.04 (5.23%) Close

$CRLBF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Costs of goods sold
Selling, general and administrative
Impairment loss
Total operating expenses
Loss from operations
Interest expense, net
Other income, net
Loss from equity method investments
Total other expense, net
Net loss attributable to non-controlling interests, net of tax
Basic and diluted (loss) per share
Basic and diluted weighted-average number of shares outstanding
Diluted loss per share (in dollars per share)
Basic weighted average number of shares outstanding (in shares)
Revenues, net
Cost of goods sold
Gross profit
Operating expenses:
Selling, general, and administrative
Impairment loss
Total operating expenses
(Loss) income from operations
Other expense, net:
Interest expense, net
Other expense, net
Total other expense, net
Loss before income taxes
Income tax expense
Net loss
Foreign currency translation differences, net of tax
Total comprehensive loss for the period
Comprehensive (loss) income attributable to non-controlling interests, net of tax
Total comprehensive loss attributable to Cresco Labs Inc.
Net (loss) income attributable to non-controlling interests, net of tax
Net loss attributable to Cresco Labs Inc.
Net loss per share - attributable to Cresco Labs Inc. shareholders:
Basic loss per share (in USD per share)
Diluted loss per share (in USD per share)
Basic weighted-average shares outstanding (in shares)
Weighted Average Number of Shares Outstanding, Diluted

Comments